Halcinonide
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 328806

CAS#: 3093-35-4

Description: Halcinonide, also known as Halog and SQ-18566, is a glucocorticoid used topically in the treatment of dermatitis, eczema, or psoriasis.


Chemical Structure

img
Halcinonide
CAS# 3093-35-4

Theoretical Analysis

MedKoo Cat#: 328806
Name: Halcinonide
CAS#: 3093-35-4
Chemical Formula: C24H32ClFO5
Exact Mass: 454.19
Molecular Weight: 454.963
Elemental Analysis: C, 63.36; H, 7.09; Cl, 7.79; F, 4.18; O, 17.58

Price and Availability

Size Price Availability Quantity
50mg USD 350 2 Weeks
100mg USD 600 2 Weeks
250mg USD 1150 2 Weeks
Bulk inquiry

Synonym: Halcinonide; Halog; SQ-18566; SQ18566; SQ 18566;

IUPAC/Chemical Name: (6aS,6bR,7S,8aS,8bS,11aS,12aS,12bS)-8b-(2-chloroacetyl)-6b-fluoro-7-hydroxy-6a,8a,10,10-tetramethyl-1,2,5,6,6a,6b,7,8,8a,8b,11a,12,12a,12b-tetradecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one

InChi Key: MUQNGPZZQDCDFT-DGRLEXMWSA-N

InChi Code: InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19-,21-,22-,23-,24+/m0/s1

SMILES Code: C[C@@]12[C@@]3(C(CCl)=O)[C@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])CCC5=CC(CC[C@]5(C)[C@@]4(F)[C@@H](O)C2)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 454.96 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Draelos ZD. Demonstration of the biphasic release of 0.1% halcinonide cream. J Drugs Dermatol. 2015 Jan;14(1):89-90. PubMed PMID: 25607913.

2: Porcu G, Serone E, De Nardis V, Di Giandomenico D, Lucisano G, Scardapane M, Poma A, Ragnini-Wilson A. Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation. PLoS One. 2015 Dec 10;10(12):e0144550. doi: 10.1371/journal.pone.0144550. eCollection 2015. PubMed PMID: 26658258; PubMed Central PMCID: PMC4689554.

3: Draelos ZD. Stratum corneum absorption kinetics of 2 potent topical corticosteroid formulations: a pilot study. Cutis. 2015 Aug;96(2):135-41. PubMed PMID: 26367752.

4: Clijsen R, Baeyens JP, Barel AO, Clarys P. Influence of the timing of ultrasound application on the penetration of corticosteroids. Skin Res Technol. 2013 Feb;19(1):e279-82. doi: 10.1111/j.1600-0846.2012.00639.x. Epub 2012 Jun 20. PubMed PMID: 22712560.

5: Baum EW. Effectiveness and Patient Acceptance of Halcinonide 0.1% Cream in 216g Jars for Large-area Steroid-responsive Dermatoses. J Clin Aesthet Dermatol. 2011 Apr;4(4):29-33. PubMed PMID: 21532875; PubMed Central PMCID: PMC3084610.

6: Bickers DR. A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis. Cutis. 1984 Aug;34(2):190-4. PubMed PMID: 6383735.

7: Shi HH, Zhu L, Yang Y, Jin HM, Li RZ, Liang ZQ, Lang JH. [Multicenter randomized clinical study of high-intensity focused ultrasound and cortical hormone in the treatment of non-neoplastic epithelial disorders of vulva]. Zhonghua Yi Xue Za Zhi. 2013 Nov 5;93(41):3291-3. Chinese. PubMed PMID: 24401626.

8: Rauschkolb EW, Bender SH, Ebling JK, McCormick GE, Rosenthal AL. Low concentration halcinonide cream in the topical management of atopic dermatitis in pediatric patients. Cutis. 1981;27(1):105-7. PubMed PMID: 7471802.

9: Zhang YD, Yao W, Wu CX, Chi QM, Zhang JY, Li M. Tropical application of halcinonide cream reduces the severity and incidence of intraperitoneal adhesions in a rat model. Am J Surg. 2002 Jul;184(1):74-77. PubMed PMID: 12152622.

10: Guenther L, Solomon AR, Voorhees JJ. A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis. Cutis. 1981 Oct;28(4):461-2, 464, 467. PubMed PMID: 7030645.